Checking ANVS unusual options activity helps you spot when traders are making outsized bets on Annovis Bio Inc before the broader market catches on. Annovis Bio Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ANVS unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ANVS unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ANVS unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ANVS unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia.
The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Catalysts rarely arrive without a footprint, and ANVS unusual options activity is often where that footprint shows up first. Our scanner tracks Annovis Bio Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ANVS unusual options volume on the call side or chasing put sweeps, Annovis Bio Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
